- Details
- Hits: 810
Cannabis is one of the most widely used psychoactive substances globally, but its effects on mental health remain a topic of significant concern and misunderstanding. With changing cannabis compositions and increasing availability, many individuals wrongly believe it has therapeutic benefits for psychiatric conditions. However, mounting evidence reveals that cannabis use, particularly at high potency and early in life, is more likely to exacerbate mental health issues rather than alleviate them. This post highlights the risks and misconceptions surrounding cannabis and its relationship with psychiatric disorders.
Misconceptions About Cannabis and Mental Health
There is a persistent misbelief that cannabis can effectively treat mental health disorders such as anxiety, depression, PTSD, and even psychosis. Surveys show that nearly half of individuals have used cannabis believing it improves anxiety or depression symptoms, while many fail to recognise its risks. These assumptions can be harmful, as scientific evidence does not support cannabis as a treatment for mental health conditions.
Instead, studies reveal that cannabis can worsen symptoms of depression, anxiety, and other psychiatric disorders. For example, cannabis use may provide short-term euphoria or relief, but its long-term impact often complicates and intensifies underlying conditions. This problem is compounded by the use of cannabis in place of proven, evidence-based treatments such as cognitive behavioural therapy (CBT) and medications like SSRIs, leaving many patients without effective care.
Cannabis Use and Psychiatric Disorders
The relationship between cannabis use and psychiatric disorders is both complex and alarming. Research indicates that individuals with existing psychiatric conditions are more likely to use cannabis. Equally, regular cannabis users—especially those who start in adolescence—are more likely to develop mental health issues later in life. The interplay between both factors creates a vicious cycle of worsening symptoms and increased vulnerability.
Heightened risks are observed with high-potency cannabis products now available, some containing THC levels far exceeding those found in previous decades. Regular use of such products is linked to earlier onset of psychotic disorders like schizophrenia, particularly in individuals with additional risk factors such as a family history of mental illness. Furthermore, cannabis use in adolescence is associated with impaired cognitive development, increased aggression, truancy, and heightened suicidal ideation, which can lead to tragic outcomes.
Warning Signs of Cannabis-Induced Mental Health Symptoms
Understanding the symptoms of cannabis-related mental illness is crucial in recognising its adverse effects. Acute intoxication may present as euphoria, sensory perception changes, or relaxation, but high doses or misuse can lead to severe outcomes. Symptoms such as paranoia, panic, hallucinations, delirium, and full-blown psychosis can result, particularly with high-THC strains or overly frequent use.
Withdrawal from regular cannabis use also brings its own set of challenges, often causing irritability, poor concentration, mood swings, and sleep disturbances. These issues can further overlap with general mental health symptoms, making the impact of cannabis even more difficult to disentangle from existing mental illnesses.
The Long-Term Consequences of Early Cannabis Use
One of the most concerning aspects of cannabis use is its long-term impact on those who begin using it at a young age. Adolescents, in particular, are at a greater risk of suffering adverse mental health outcomes as they are in a critical period of brain development. Regular or high-potency cannabis use during this stage is linked to severe cognitive impairment, hindered educational performance, and persistent mental health challenges into adulthood.
Cannabis is also associated with increased rates of suicidality, from thoughts and attempts to completed suicides. For young people grappling with mental health struggles, cannabis often worsens the severity of their conditions, driving them further from help.
High Potency Cannabis—A Growing Threat to Mental Health
Today’s cannabis is vastly different from the substances available decades ago. While cannabis in the 1990s rarely exceeded 20% THC potency, current products can contain up to 80% THC, making them exponentially stronger. This increase in potency amplifies the drug’s psychoactive effects and poses a greater threat to overall mental health. Studies in Europe have already recorded a troubling correlation between exposure to high-potency cannabis and the onset of psychotic disorders.
Additionally, one-time use of strong cannabis products can trigger temporary psychotic episodes in some individuals, further increasing the likelihood of developing chronic psychotic disorders.
Evidence-Based Treatments Are a Better Approach
Despite widespread misconceptions, cannabis use lacks evidence as a treatment for mental health disorders. This false narrative encourages vulnerable individuals to self-medicate with cannabis, diverting them from evidence-based treatments that are effective, safe, and well-researched. Established therapies like CBT and SSRI medications have been proven to significantly improve serious mental health issues, yet they remain underused due to misinformation surrounding alternative options like cannabis.
Choosing cannabis over tested treatment approaches means exposing oneself to a host of psychological risks with little to no benefit. For individuals battling mental illness, prioritising scientifically-backed treatments is essential in achieving long-term stability and recovery.
A Call for Caution
The link between cannabis and mental health cannot be ignored. High-potency cannabis and early exposure significantly increase the risks of developing or worsening psychiatric conditions. This drug is not benign nor an alternative to proper healthcare—it is a substance capable of derailing the mental well-being of those already struggling or vulnerable.
Education and awareness are critical in confronting these myths. While society shifts towards greater cannabis accessibility, it is vital to approach its use with an understanding of the very real risks.
By re-focusing on evidence-based treatments and creating greater awareness around cannabis-related mental health challenges, we can help individuals make informed decisions that prioritise their safety and long-term health.
Source: AMA
- Details
- Hits: 440
Remember when they said weed was harmless? Tell that to the nearly 900,000 Americans who ended up in emergency rooms last year due to cannabis. That’s right – while pot advocates preach peace and love, emergency departments across the nation are drowning in cannabis-related crises.
The Numbers Don’t Lie
In 2023, U.S. emergency departments logged an estimated 896,418 cannabis-related visits – a 4.6% increase from the previous year. This isn’t just a statistical blip; it represents nearly 12% of all drug-related emergency department visits nationwide. That’s one in eight drug-related ER visits attributed to a substance that proponents insist is “completely safe.”
The data paints a particularly troubling picture for young adults. Those aged 18-25 face the highest risk, with a staggering 676 visits per 100,000 individuals – more than double the national average of 268 per 100,000. So much for the argument that cannabis helps young people “mellow out.”
While individuals aged 26-44 account for 41.6% of all cannabis-related ED visits, it’s the concentration among young adults that should set off alarm bells. These aren’t just numbers; they represent thousands of young lives disrupted by what many consider a “harmless plant.”
The Demographic Divide
The racial and ethnic disparities in cannabis-related ED visits reveal a troubling pattern:
- Black individuals face a rate of 717 visits per 100,000 – more than four times higher than White individuals (167 per 100,000)
- Non-Hispanic or Latino individuals show significantly higher rates (281 per 100,000) compared to Hispanic or Latino individuals (148 per 100,000)
These disparities raise serious questions about targeted marketing, access to healthcare resources, and the social determinants driving these stark differences. The cannabis industry’s rapid expansion into urban areas and communities of color isn’t just coincidental – it’s strategic.
Consistent Crisis Throughout the Year
The Northeast region leads with 389 visits per 100,000 individuals, nearly double the rate seen in the West (198 per 100,000). This regional disparity becomes even more interesting when you consider that the South, despite its generally stricter cannabis laws, accounts for 41.1% of all cannabis-related ED visits.
Unlike seasonal substances, cannabis-related ED visits maintain a disturbing consistency across all quarters, ranging from 247 to 278 visits per 100,000. This steady stream of emergencies contradicts the notion that cannabis use is primarily recreational or occasional. The data suggests a pattern of regular use leading to regular problems.
Males represent 56% of cannabis-related ED visits, with a rate of 303 per 100,000 compared to females at 233 per 100,000. While this gap might seem modest, it represents thousands of additional male patients annually streaming into already overwhelmed emergency departments.
Wake Up and Smell the Truth
While politicians chase tax dollars and dispensaries multiply like weeds, emergency rooms tell the real story. Nearly 900,000 emergency visits in one year isn’t a statistic – it’s a scandal. The cannabis industry is smoking profits while hospitals deal with the fallout.
Here’s your reality check: that “harmless herb” is sending hundreds of thousands to the ER annually. But hey, at least it’s “natural,” right?
Maybe it’s time we all stopped pretending weed is consequence-free. Emergency rooms don’t lie – even if the cannabis industry does.
Source: National Estimates from Drug-Related Emergency Department Visits, 2023 – SAMHSA
- Details
- Hits: 662
In a move that should concern parents and public health advocates alike, DoorDash has decided to join the troubling trend of normalising drug use by launching home delivery of cannabis products. The same app that brings you tacos and groceries will now deliver THC-laden gummies and beverages right to your doorstep. How convenient – and how utterly irresponsible.
Marketing Spin or Drug Delivery?
The company’s gleaming press statements talk about “helping eligible customers find new products to safely enjoy while they unwind.” Let’s call this what it really is: making drug consumption as casual as ordering a pizza. Their marketing spin about “evolving preferences” and “decompressing” cleverly masks the reality that they’re essentially becoming drug runners with a fancy app.
Sure, they’re technically staying within federal law by limiting products to less than 0.3% delta-9 THC on a dry weight basis. They’ve also implemented age verification systems, much like they do for alcohol delivery. But these safeguards hardly address the broader societal implications of making intoxicating substances available at the tap of a screen.
A Troubling Vision of Mainstream Cannabis Consumption Trends
Most concerning is the company’s cited Harris Poll survey, suggesting that 75% of adults aged 21-65 are considering incorporating THC/CBD products into their 2025 routine. Rather than raising alarm bells about this disturbing trend, DoorDash seems to be celebrating it as a business opportunity.
Some cannabis industry executives are, predictably, jumping for joy. Adam Terry, CEO of Cantrip, speaks enthusiastically about “breaking into the new ecosystem of direct delivery.” However, more sobering voices like Mike Khemmoro from Mango Cannabis raise valid concerns about the looser regulatory framework for hemp-derived products compared to state-regulated cannabis businesses.
States Struggle to Regulate Intoxicating Hemp Products Amid New Moves
The timing couldn’t be more problematic, with several states including Illinois grappling with regulations on intoxicating hemp products. New Jersey recently saw a ban put on hold, while California implemented emergency regulations last September. Instead of waiting for clearer regulatory frameworks, DoorDash has chosen to barrel ahead.
The company’s partnership with Cann, offering promotional discounts on THC drinks, feels particularly tone-deaf. Nothing says “responsible business practices” quite like discount drugs, right?
What’s next? Will we see “bundle deals” where you can add THC gummies to your burger order? Perhaps a “happy hour” for hemp-derived products? The slippery slope from here isn’t hard to imagine.
While DoorDash executives celebrate their expansion into this controversial market, communities across America continue to struggle with substance abuse issues. The normalisation of drug use through mainstream delivery platforms only serves to compound these challenges.
Profiting from Public Health Risks? Corporate America’s Priorities
The harsh reality is that this move represents everything wrong with corporate America’s rush to profit from substances that should remain strictly controlled. DoorDash may have found another revenue stream, but at what cost to public health and social responsibility?
Perhaps it’s time for regulators and lawmakers to take a harder look at whether delivery apps should be permitted to branch into controlled substances at all. Until then, we can only hope that consumers will think twice before treating drug delivery with the same casualness as ordering their daily coffee.
After all, just because something can be delivered to your door doesn’t mean it should be. (WRD News)
- Details
- Hits: 600
More cannabis – more alcohol and tobacco!Cannabis Use and Alcohol Consumption: Alcohol remains one of the leading contributors to preventable deaths in the United States, ranking behind tobacco and physical inactivity. The study highlighted that cannabis use was positively associated with alcohol consumption, with participants consuming an average of 0.45 additional alcohol-containing drinks on cannabis use days compared to non-use days. Previous research corroborates this finding, with studies showing that co-use of cannabis and alcohol often leads to an increased duration of intoxication and heightened consumption. This co-use behaviour is complex—sometimes substitutionary (replacing alcohol with cannabis) but often complementary (enhancing the intoxicating effects of both substances).
Cannabis Use and Cigarette Smoking: Cigarette smoking claims approximately 480,000 lives annually in the U.S., primarily due to its role in diseases such as lung cancer, chronic obstructive pulmonary disease, and cardiovascular illnesses. The study found that cannabis use was associated with an increase in cigarette smoking, with participants smoking an additional 0.63 cigarettes on cannabis use days. Historically, individuals who smoke cigarettes are more likely to use cannabis, and cannabis use has been linked to reduced smoking cessation success and increased risks of relapse. The findings align with earlier studies that identified a temporal association between cannabis use and subsequent cigarette consumption.
(For complete research: Science Direct)
- Details
- Hits: 600
Cannabis use is often seen as harmless, but growing evidence highlights its dangers. From addiction to its effects on mental health, the consequences of using cannabis are far-reaching. With the increased accessibility and potency of cannabis products, it’s time to understand the risks it poses, particularly to young people.
This post dives into cannabis addiction, withdrawal symptoms, and the broader health implications, aiming to raise awareness of its effects on individuals and society.
Is Cannabis Addictive?
A common myth about cannabis is that it isn’t addictive. However, research proves otherwise. Cannabis addiction, formally known as cannabis use disorder (CUD), occurs when habitual use leads to dependency, which can negatively impact various aspects of life. Alarmingly, one in ten cannabis users develops CUD, with daily users facing an even higher risk—about one in three.
The potency of modern cannabis products contributes to its addictive nature. Today’s cannabis often contains far higher levels of THC (the psychoactive compound in cannabis) than in previous decades, increasing the likelihood of addiction. Additionally, frequent use leads to tolerance, meaning individuals require larger amounts to experience the same effects, further deepening dependency.
Cannabis Withdrawal Symptoms
A critical aspect of cannabis addiction is the challenge of withdrawal. When regular users stop consuming cannabis, they often face unpleasant withdrawal symptoms. These symptoms include:
- Anxiety and irritability
- Insomnia or disturbed sleep
- Lack of motivation
- Restlessness
- Appetite changes
While withdrawal is not life-threatening, the discomfort can last for weeks due to the drug’s long duration in the body. These symptoms often cause individuals to resume use, perpetuating a cycle of dependency that is tough to break.
Why Young People Are at Greater Risk
Young people are especially vulnerable to the risks of cannabis use. Early exposure significantly increases the likelihood of addiction. Studies reveal that individuals who begin using cannabis during their teenage years are twice as likely to develop cannabis addiction compared to those who start later in life.
More concerning is the impact on adolescent brain development. The teenage years are critical for cognitive and emotional growth, and cannabis use can disrupt memory, learning ability, and decision-making skills. Additionally, young users face an elevated risk of mental health issues, including anxiety, depression, and psychosis.
The rise of cannabis edibles, such as gummies, sweets, and chocolates, further exacerbates the risks to young people. These products, often marketed in appealing packaging, have led to a shocking increase in accidental ingestion among children. Between 2017 and 2021, cases of paediatric cannabis edible poisonings surged by 1300%, largely due to improper storage at home.
The Wider Impact of Cannabis Use
Cannabis use has far-reaching social and health consequences beyond the individual. Daily or heavy use often leads to disruptions in work, school, and relationships, leaving families and communities to pick up the pieces. Additionally, cannabis addiction has been linked to increased emergency room visits, particularly among adolescents, as stronger cannabis products lead to more severe side effects.
Using cannabis as a self-treatment for issues like anxiety or depression is another concern. While some believe it provides relief, research suggests it often worsens these conditions over time, creating a damaging cycle of dependency and deteriorating mental health.
Raising Awareness of Cannabis Risks
Understanding the risks associated with cannabis use is the first step towards addressing its growing prevalence. Misconceptions about its safety contribute to its popularity, but evidence shows that it is far from harmless. Cannabis addiction, withdrawal challenges, and its disproportionately negative impact on young people demand attention and action.
By raising awareness of these issues, we can challenge the narrative that cannabis is a “safe” recreational drug and focus on creating healthier communities. Protecting young people and educating others about the real dangers of cannabis use is crucial for building a more informed society.
The Long-Term Implications of Dependency
The dangers of cannabis addiction extend beyond withdrawal or even the individual user. Substance dependency has a domino effect, affecting families, workplaces, and entire communities. Addressing the risks associated with cannabis use today will pave the way for a healthier, more secure future.
Keywords like ‘Cannabis addiction’, ‘Cannabis withdrawal’, and ‘impact on young people’ shouldn’t just dominate search engines—they should dominate discussions on public health. Recognising the facts and implementing change can safeguard future generations from the traps of cannabis dependency. Stay vigilant, stay informed, and work towards a brighter tomorrow. (Source: AMA Med Hub)